PTN Palatin Technologies, Inc.
Palatin Technologies, Inc. (PTN) is confirmed to report earnings on November 17, 2026, before the market open. The consensus earnings estimate is a loss of $0.32 per share.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Palatin Technologies, Inc.
Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential.
Sector
Healthcare
Industry
Diagnostic Substances
Charts powered in part by Lightweight Charts™ by TradingView.